The post-translational modification, SUMOylation, and cancer (Review)

Area of Science:

• Molecular Biology
• Biochemistry
• Cell Biology

Background:

• SUMOylation is a reversible post-translational modification regulating critical cellular processes like DNA repair, immune response, and apoptosis.
• Four SUMO isoforms (SUMO1, SUMO2/3, SUMO4) exist, and the SUMO pathway is vital for gene expression, signaling, and genomic integrity in eukaryotes.
• SUMOylation plays a significant role in various stages of cancer, including initiation, progression, and metastasis.

Purpose of the Study:

• To review the fundamental concepts of the SUMOylation system.
• To summarize the involvement of SUMO proteins in cancer development and progression.
• To highlight SUMOylation as a potential therapeutic target for cancer treatment.

Main Methods:

• This review synthesizes existing literature on SUMOylation.
• It outlines the SUMOylation catalytic cycle (maturation, activation, conjugation, ligation, de-modification).
• The review discusses the link between SUMOylation dysregulation and cancer pathogenesis.

Main Results:

• SUMOylation is implicated in DNA damage response, cell cycle control, and apoptosis.
• Aberrant SUMOylation is frequently observed in cancer cells, influencing proliferation and metastasis.
• The SUMO pathway's dysregulation is a hallmark of many cancers.

Conclusions:

• SUMOylation is a critical regulator of cellular functions and its deregulation is associated with human diseases, especially cancer.
• Understanding SUMOylation's role in cancer provides insights into disease mechanisms.
• Targeting the SUMO system offers a promising strategy for novel cancer therapies.